The Royal Liverpool & Broadgreen University Hospital’s community anticoagulation service has been shortlisted for the prestigious Anticoagulation Achievement Awards.
The ceremony will be held on 10th October in the Houses of Commons, London, and hosted by hosted by Lyn Brown MP, chair of the All Party Group for Thrombosis.
First launched in 2017, the awards invite applications from teams and individuals across secondary, primary and community services within the UK, who can demonstrate innovation and excellence in delivering anticoagulation services, resources or individual leadership.
The Liverpool Anticoagulation Service operates 37 clinics across 23 sites in the community, with patients being seen within 1 mile of their GP surgery or in their own homes. The service has in excess of 83,000 patient contacts per year and operates an advice line for patients and healthcare professionals. The team is jointly led clinically by a specialist nurse and pharmacist, assisted by an operations manager and comprises of nurse specialists, pharmacists, pharmacy technicians and admin.
“We are thrilled to be shortlisted for these awards,” said Lyndsey Stanley, joint clinical lead of the Liverpool Anticoagulation Service.
Our team provides a high quality, safe and convenient service for highly complex patients in the community. We have demonstrated improved clinical and patient outcomes through face to face engagement with patients.
The high standard of care given to patients under the service is reflected in 99.8% of those rating the service as excellent or good. Prior to the establishment of the service, patients often had a venous blood sample taken from their arm and were then dosed by telephone if they were unstable, or had to await their result and dose in the post.
“In the current service, patients have been moved out of the hospital into convenient community clinics and are given a convenient appointment time,” explained Janet Davies, joint clinical lead of the Liverpool Anticoagulation Service. They are then seen face to face by a clinician and are tested using point of care devices which provide an instant INR result from a small sample of blood from their finger.
“The clinician assesses the result, advises the patient of the correct dose of anticoagulant medication to take, provides them with appropriate advice and agrees their next appointment before they leave the clinic. Housebound patients receive a service of equal quality in their own homes.”
Non-medical prescribers within the team prescribe for patients when they initially start treatment and prescribe alternatives for patients undergoing procedures that require them to temporarily stop their routine treatment, thus ensuring patient safety and convenience.
The awards are hosted by leading charities: Anticoagulation UK, Thrombosis UK, AF Association, Arrhythmia Alliance and leading training establishments: Anticoagulation in Practice and the National Centre for Anticoagulation Training.
In a statement, they said: “1 in 4 people worldwide die of conditions caused by blood clots, also known by the medical term ‘thrombosis’ – which is the underlying cause of the world’s top three cardiovascular killers: heart attack, stroke and venous thromboembolism (VTE).”
“There is overwhelming clinical evidence, embedded in approved national guidelines, to support prevention, protection and improved patient outcomes and experience. We hope these awards will not only recognize the outstanding work of the medical centres, teams and individuals involved, but also act as a learning resource for others.”